{"id":"human-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Immune-related adverse events"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Tumorigenicity risk"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Human stem cells are undifferentiated cells capable of self-renewal and differentiation into specialized cell types. When administered, they can engraft into damaged tissues, differentiate into functional cell types to replace lost tissue, and secrete paracrine factors (cytokines, growth factors) that reduce inflammation and promote endogenous repair mechanisms. The exact therapeutic mechanism depends on the specific stem cell type and indication being targeted.","oneSentence":"Human stem cells differentiate and regenerate damaged or diseased tissues by replacing lost cells and secreting therapeutic factors.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:47:10.018Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06498635","phase":"PHASE3","title":"Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-04-01","conditions":"Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":306},{"nctId":"NCT07496372","phase":"PHASE3","title":"Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart Failure (NYHA Class III-IV)","status":"NOT_YET_RECRUITING","sponsor":"Help Therapeutics","startDate":"2026-04-30","conditions":"Heart Failure","enrollment":80},{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT06321198","phase":"NA","title":"A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2024-02-10","conditions":"Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)","enrollment":12},{"nctId":"NCT06912633","phase":"PHASE2","title":"Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)","status":"RECRUITING","sponsor":"jCyte, Inc","startDate":"2025-06-20","conditions":"Retinitis Pigmentosa","enrollment":60},{"nctId":"NCT07012044","phase":"PHASE1","title":"A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-10-30","conditions":"Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":47},{"nctId":"NCT05071222","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-19","conditions":"Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency","enrollment":7},{"nctId":"NCT05665166","phase":"PHASE1, PHASE2","title":"Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type II","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Manchester","startDate":"2023-06-01","conditions":"Mucopolysaccharidosis II","enrollment":5},{"nctId":"NCT00792948","phase":"PHASE2","title":"Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-01","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":97},{"nctId":"NCT07388524","phase":"PHASE3","title":"Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-09","conditions":"Lung Non-Small Cell Carcinoma","enrollment":336},{"nctId":"NCT01303146","phase":"PHASE2","title":"Efficacy METAZYM for the Treatment Metachromatic Leukodystrophy Treated With Hematopoietic Stem Cell Transplantation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-10","conditions":"Metachromatic Leukodystrophy","enrollment":1},{"nctId":"NCT04476901","phase":"PHASE2","title":"Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Joshua M Hare","startDate":"2021-05-07","conditions":"Non-ischemic Dilated Cardiomyopathy","enrollment":136},{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT07332338","phase":"","title":"Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition","status":"AVAILABLE","sponsor":"StemCyte, Inc.","startDate":"","conditions":"Post-COVID-19 Condition, Post-COVID Condition, Post-COVID Syndrome","enrollment":""},{"nctId":"NCT07488663","phase":"NA","title":"MODELING OBSESSIVE COMPULSIVE DISORDER AND EXPLORING TREATMENT RESPONSE USING INNOVATIVE THERAPIES AND STEM CELLS","status":"ENROLLING_BY_INVITATION","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2023-04-30","conditions":"Obsessive - Compulsive Disorder","enrollment":60},{"nctId":"NCT05477563","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-08-02","conditions":"Beta-Thalassemia, Thalassemia, Hematologic Diseases","enrollment":26},{"nctId":"NCT02032004","phase":"PHASE3","title":"Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2014-03-03","conditions":"Chronic Heart Failure","enrollment":565},{"nctId":"NCT03267433","phase":"PHASE3","title":"Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2017-11-27","conditions":"Mantle Cell Lymphoma","enrollment":689},{"nctId":"NCT07339111","phase":"PHASE3","title":"Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis","status":"RECRUITING","sponsor":"Medipost, Inc.","startDate":"2026-03-11","conditions":"Knee Cartilage Defects","enrollment":300},{"nctId":"NCT07485647","phase":"PHASE2","title":"Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing","status":"NOT_YET_RECRUITING","sponsor":"Eden Biltibo","startDate":"2026-05","conditions":"Multiple Myeloma","enrollment":50},{"nctId":"NCT07485751","phase":"EARLY_PHASE1","title":"Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Zigong Mental Health Center","startDate":"2026-03","conditions":"Schizophrenia Negative Type","enrollment":15},{"nctId":"NCT03180216","phase":"PHASE1","title":"T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's National Research Institute","startDate":"2017-02-15","conditions":"Viral Infections, Bone Marrow Transplant Infection","enrollment":32},{"nctId":"NCT06816134","phase":"PHASE2","title":"Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-01-30","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell","enrollment":48},{"nctId":"NCT04948333","phase":"PHASE3","title":"Asciminib Treatment Optimization in ≥ 3rd Line CML-CP","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-10-13","conditions":"Chronic Myelogenous Leukemia","enrollment":199},{"nctId":"NCT07476183","phase":"PHASE1","title":"Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia","status":"NOT_YET_RECRUITING","sponsor":"Apriligen, Inc.","startDate":"2026-03","conditions":"RPS19 Deficient Diamond-Blackfan Anemia","enrollment":4},{"nctId":"NCT03167203","phase":"PHASE1, PHASE2","title":"A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"Astellas Institute for Regenerative Medicine","startDate":"2018-01-08","conditions":"Macular Degenerative Disease","enrollment":36},{"nctId":"NCT07471698","phase":"PHASE1, PHASE2","title":"hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Help Therapeutics","startDate":"2026-10-20","conditions":"Ischemic Heart Failure, CABG-patients","enrollment":16},{"nctId":"NCT07102342","phase":"PHASE1","title":"This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.","status":"RECRUITING","sponsor":"iRegene Therapeutics Co., Ltd.","startDate":"2026-01-12","conditions":"Parkinson Disease","enrollment":5},{"nctId":"NCT05651997","phase":"NA","title":"Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2026-12","conditions":"Articular Cartilage Defect, Chondral Defect, Osteochondritis","enrollment":80},{"nctId":"NCT00543374","phase":"PHASE3","title":"Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2007-09-17","conditions":"Crohn's Disease","enrollment":98},{"nctId":"NCT00877903","phase":"PHASE2","title":"Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2009-03-30","conditions":"Myocardial Infarction","enrollment":220},{"nctId":"NCT04819841","phase":"PHASE1, PHASE2","title":"Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease","status":"RECRUITING","sponsor":"Kamau Therapeutics","startDate":"2021-11-15","conditions":"Sickle Cell Disease","enrollment":15},{"nctId":"NCT00683722","phase":"PHASE2","title":"PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-03-20","conditions":"Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis","enrollment":62},{"nctId":"NCT00482092","phase":"PHASE3","title":"Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2007-09-17","conditions":"Crohn's Disease","enrollment":330},{"nctId":"NCT07032038","phase":"PHASE1, PHASE2","title":"First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant","status":"NOT_YET_RECRUITING","sponsor":"Rinri Therapeutics","startDate":"2026-05","conditions":"Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy","enrollment":20},{"nctId":"NCT01233960","phase":"PHASE3","title":"Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2010-11-29","conditions":"Crohn's Disease","enrollment":73},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT07458854","phase":"NA","title":"Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2014-10-14","conditions":"Hematologic Malignacy, Autologous Hematopoietic Stem Cell Transplantation","enrollment":15},{"nctId":"NCT04965597","phase":"PHASE2","title":"Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2022-04-19","conditions":"Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia","enrollment":40},{"nctId":"NCT06564233","phase":"NA","title":"Supportive Care Intervention for Outpatient Stem Cell Transplant Patients","status":"RECRUITING","sponsor":"Victor Wang","startDate":"2024-10-21","conditions":"Hematopoietic Stem Cell Transplantation, Cancer","enrollment":90},{"nctId":"NCT03366168","phase":"","title":"Taste Bud-Derived Stem Cells in Humans","status":"RECRUITING","sponsor":"National Institute on Aging (NIA)","startDate":"2017-12-18","conditions":"Diabetes","enrollment":250},{"nctId":"NCT04375631","phase":"PHASE1","title":"CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2020-12-03","conditions":"Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome","enrollment":120},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT00026312","phase":"PHASE3","title":"Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-10-26","conditions":"Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma","enrollment":1449},{"nctId":"NCT03896568","phase":"PHASE1","title":"MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-02-12","conditions":"IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma","enrollment":36},{"nctId":"NCT07451613","phase":"PHASE1, PHASE2","title":"Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease","status":"NOT_YET_RECRUITING","sponsor":"Leslie Thompson","startDate":"2026-03","conditions":"Huntington Disease","enrollment":21},{"nctId":"NCT01520623","phase":"NA","title":"Complement and Graft-versus-host Disease","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-04","conditions":"Allografted With Myeloablative Conditioning","enrollment":70},{"nctId":"NCT03964792","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-11-12","conditions":"Sickle Cell Disease","enrollment":6},{"nctId":"NCT04592640","phase":"EARLY_PHASE1","title":"Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-09-17","conditions":"Chronic Kidney Diseases, Calciphylaxis, Calcific Uremic Arteriolopathy","enrollment":9},{"nctId":"NCT03601078","phase":"PHASE2","title":"An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma","status":"COMPLETED","sponsor":"Celgene","startDate":"2018-12-13","conditions":"Multiple Myeloma","enrollment":312},{"nctId":"NCT03849651","phase":"PHASE2","title":"TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-01-31","conditions":"Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)","enrollment":69},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT06944522","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease","status":"RECRUITING","sponsor":"BlueRock Therapeutics","startDate":"2025-06-17","conditions":"Parkinsons Disease (PD)","enrollment":102},{"nctId":"NCT07412210","phase":"EARLY_PHASE1","title":"Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2026-04","conditions":"Systemic Lupus Erythenlatosus Nephritis","enrollment":9},{"nctId":"NCT04195633","phase":"PHASE2","title":"Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2021-01-25","conditions":"Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":60},{"nctId":"NCT07440654","phase":"NA","title":"Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2026-03-01","conditions":"aGVHD Prophylaxis","enrollment":40},{"nctId":"NCT06947746","phase":"NA","title":"HiSCs in the Treatment of Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2025-05-01","conditions":"Rheumatoid Arthritis (RA)","enrollment":15},{"nctId":"NCT07433517","phase":"EARLY_PHASE1","title":"VGN-Ex05e in Patients With Autism Spectrum Disorder Associated With Severe Self-Injurious and Aggressive Behaviors","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2026-04","conditions":"Autism Spectrum Disorder","enrollment":6},{"nctId":"NCT04684368","phase":"PHASE2","title":"A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2021-07-13","conditions":"Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma","enrollment":160},{"nctId":"NCT04886726","phase":"PHASE1","title":"PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2021-12-23","conditions":"Graft Versus Host Disease","enrollment":18},{"nctId":"NCT07216443","phase":"PHASE2","title":"Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome","status":"RECRUITING","sponsor":"Orca Biosystems, Inc.","startDate":"2025-12-09","conditions":"Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia","enrollment":80},{"nctId":"NCT06918808","phase":"PHASE2","title":"DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2025-05-19","conditions":"Perianal Fistula Due to Crohn's Disease","enrollment":36},{"nctId":"NCT03007147","phase":"PHASE3","title":"Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-08-08","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":475},{"nctId":"NCT06364774","phase":"PHASE1, PHASE2","title":"ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2025-04-14","conditions":"Beta-Thalassemia","enrollment":12},{"nctId":"NCT04396899","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure","status":"RECRUITING","sponsor":"University Medical Center Goettingen","startDate":"2020-02-03","conditions":"Heart Failure","enrollment":53},{"nctId":"NCT07408583","phase":"PHASE1, PHASE2","title":"Prenatal Transplantation for Fetuses With Fanconi Anemia","status":"NOT_YET_RECRUITING","sponsor":"Agnieszka Czechowicz","startDate":"2026-07","conditions":"Fanconi Anemia, Anemia, Hypoplastic, Congenital, Congenital Bone Marrow Failure Syndromes","enrollment":12},{"nctId":"NCT05135091","phase":"PHASE3","title":"Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))","status":"RECRUITING","sponsor":"Neurona Therapeutics","startDate":"2022-06-16","conditions":"Mesial Temporal Lobe Epilepsy","enrollment":88},{"nctId":"NCT07413549","phase":"PHASE1, PHASE2","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","status":"RECRUITING","sponsor":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","startDate":"2025-02-25","conditions":"Decompensated Hepatitis B Cirrhosis","enrollment":76},{"nctId":"NCT03467386","phase":"PHASE1","title":"Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia","status":"SUSPENDED","sponsor":"City of Hope Medical Center","startDate":"2018-03-19","conditions":"Acute Myeloid Leukemia","enrollment":56},{"nctId":"NCT07413978","phase":"PHASE1, PHASE2","title":"A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Changchun Tuohua Pharmaceutical Co., Ltd.","startDate":"2025-04-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":36},{"nctId":"NCT06986070","phase":"PHASE1","title":"Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).","status":"RECRUITING","sponsor":"SMSbiotech","startDate":"2025-06-13","conditions":"Chronic Obstructive Lung Disease","enrollment":18},{"nctId":"NCT05697718","phase":"PHASE1","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke","status":"COMPLETED","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2023-04-10","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT06565026","phase":"EARLY_PHASE1","title":"CS-206 in Patients With Sickle Cell Disease","status":"RECRUITING","sponsor":"CorrectSequence Therapeutics Co., Ltd","startDate":"2024-09-02","conditions":"Sickle Cell Disease","enrollment":5},{"nctId":"NCT06340048","phase":"PHASE1, PHASE2","title":"Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Help Therapeutics","startDate":"2023-09-05","conditions":"Heart Failure","enrollment":36},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT06949137","phase":"PHASE1","title":"Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture","status":"ACTIVE_NOT_RECRUITING","sponsor":"Help Therapeutics","startDate":"2025-06-20","conditions":"Osteoporosis in Post-menopausal Women, Osteoporosis","enrollment":9},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT06716853","phase":"PHASE1, PHASE2","title":"A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma","status":"TERMINATED","sponsor":"Genenta Science","startDate":"2024-10-22","conditions":"Clear Cell RCC","enrollment":10},{"nctId":"NCT03866109","phase":"PHASE1, PHASE2","title":"A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genenta Science","startDate":"2019-03-05","conditions":"Glioblastoma Multiforme","enrollment":27},{"nctId":"NCT03851614","phase":"PHASE2","title":"Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-04-08","conditions":"Mismatch Repair Proficient Colorectal Cancer, Pancreatic Adenocarcinoma, Leiomyosarcoma","enrollment":90},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT01625351","phase":"PHASE1","title":"A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2012-08-20","conditions":"Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor","enrollment":23},{"nctId":"NCT07367451","phase":"","title":"Effects of Propolis Flavonoids on TLR4 Signaling and Inflammation in Human PDLSCs In Vitro","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-01-25","conditions":"Inflammatory Cytokine Expression","enrollment":20},{"nctId":"NCT07376460","phase":"","title":"Proteomic and Biological Characterisation of Plasma for the Study of Changes Following Ovarian Reactivation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI Alicante","startDate":"2026-02","conditions":"Poor Ovarian Response, Ovarian Reactivation","enrollment":10},{"nctId":"NCT01733186","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects","status":"COMPLETED","sponsor":"Medipost, Inc.","startDate":"2013-01-07","conditions":"Degeneration Articular Cartilage Knee","enrollment":12},{"nctId":"NCT06815939","phase":"NA","title":"Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer","status":"RECRUITING","sponsor":"DL Analytics","startDate":"2025-02-12","conditions":"Human Papillomavirus (HPV), Cervical Intraepithelial Neoplasia, Uterine Cervical Neoplasms","enrollment":10000},{"nctId":"NCT04262167","phase":"PHASE1","title":"Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-10-22","conditions":"Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease","enrollment":24},{"nctId":"NCT02286089","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2015-04-01","conditions":"Age-Related Macular Degeneration","enrollment":24},{"nctId":"NCT06600581","phase":"PHASE2","title":"Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunis, Inc.","startDate":"2024-12-19","conditions":"Muscle Performance, Sarcopenic Obesity","enrollment":55},{"nctId":"NCT07341698","phase":"NA","title":"Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-01-12","conditions":"Allogeneic Hematopoietic Stem Cell Transplantation Recipient","enrollment":110},{"nctId":"NCT02677350","phase":"PHASE1","title":"AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)","status":"WITHDRAWN","sponsor":"Joshua M Hare","startDate":"2019-12-01","conditions":"Crohn's Disease, Fistulizing Crohn's Disease, Stem Cells","enrollment":""},{"nctId":"NCT00336024","phase":"PHASE3","title":"Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-10-22","conditions":"Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":91},{"nctId":"NCT04118088","phase":"PHASE4","title":"A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula","status":"TERMINATED","sponsor":"Takeda","startDate":"2020-12-22","conditions":"Crohn's Disease, Complex Perianal Fistula","enrollment":53},{"nctId":"NCT06013423","phase":"PHASE2","title":"Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-07-23","conditions":"Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":54},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT03403699","phase":"","title":"Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2018-01-11","conditions":"Diabetes Complications, Diabetic Retinopathy","enrollment":20},{"nctId":"NCT06620809","phase":"PHASE1","title":"The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-03-28","conditions":"Neuromyelitis Optica Spectrum Disorders","enrollment":69},{"nctId":"NCT06612710","phase":"PHASE1","title":"The Safety and Efficacy of NouvSoma001 in Ischemic Stroke","status":"RECRUITING","sponsor":"Wei Wang","startDate":"2025-11-30","conditions":"Ischemic Stroke","enrollment":69},{"nctId":"NCT06415461","phase":"PHASE1","title":"A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2024-05-10","conditions":"Sacroiliac; Backache, Pain, Back","enrollment":9},{"nctId":"NCT06954441","phase":"PHASE3","title":"V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency","status":"RECRUITING","sponsor":"On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.","startDate":"2025-08-15","conditions":"Immunodeficiencies, Primary Immunodeficiencies (PID), Agammaglobulinemia","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1781,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["OK99"],"phase":"phase_3","status":"active","brandName":"Human Stem Cells","genericName":"Human Stem Cells","companyName":"Celavie Bioscences, LLC","companyId":"celavie-bioscences-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}